SG1408 is an innovative bi-specific antibody therapeutic biological candidate developed by CNBG-Sumgen. It has received
SG12473 is an innovative bi-specific antibody therapeutic biological candidate developed by Sumgen.
SG2501 is an innovative bi-specific antibody therapeutic biological candidate developed by Sumgen. It has received IND c
SG404 is an innovative antibody fusion protein therapeutic biological candidate developed by Sumgen. It has received IND
Copyright Rm. 301, F3, Building C, Block 2, No. 688, Bin'an Road, Changhe Zhejiang ICP Filing No. 18039044